Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when COO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCooper Companies records $271.6M charge for embryo culture media recall settlements
Filed June 4, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
high
Item 2.02 verify on EDGAR →
-
high
Settlement agreements now cover over 95% of claimants who alleged embryo loss or reduced viability from three recalled lots of LifeGlobal embryo culture media. Most payments expected during fiscal 2026.
Item 2.02 verify on EDGAR → -
medium
Starting mid-March 2026, procedural acceleration of cases, additional claimant data, updated damage valuations, and significantly higher projected defense costs prompted management to reassess exposure and conclude a loss was probable.
Item 2.02 verify on EDGAR → -
medium
Cooper Companies reported fiscal Q2 2026 results for the quarter ended April 30, 2026 via press release. Specific financial metrics are in the attached exhibit.
Item 2.02 verify on EDGAR →
Summary
Cooper Companies disclosed a substantial $271.6 million charge to resolve litigation stemming from a December 2023 recall of embryo culture media products. The recall affected three lots of CooperSurgical's LifeGlobal media, generating over 140 lawsuits and 1,500+ claims from patients alleging embryo loss or reduced viability.
While early claims were largely covered by insurance, the company's exposure assessment changed dramatically in mid-March 2026 when multiple cases accelerated procedurally, defense costs escalated, and damage valuations increased. Retail investors should note this is a one-time charge that will hit fiscal 2026 results, with most cash payments expected this year.
The settlement covers over 95% of known claimants, suggesting the company is moving to close this chapter. However, three putative class actions remain uncertified, and roughly 5% of claims are unresolved. Watch for any disclosure of class certification decisions or additional claimants emerging, as these could signal further exposure beyond the current accrual.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On June 4, 2026, The Cooper Companies, Inc. (the “Company”) issued a press release reporting results for its fiscal second quarter ended April 30, 2026.
The company disclosed its fiscal second quarter 2026 financial results through a press release. The quarter ended April 30, 2026. Specific financial metrics are contained in the attached press release, which is incorporated by reference but not included in the 8-K body text.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
As of June 4, 2026, more than 140 lawsuits were filed, including three putative class actions (none of which has been certified), and over 1,500 claimants have been proffered to the Company.
The recall generated over 140 lawsuits including three putative class actions (none certified) and over 1,500 total claimants alleging damages from embryo loss or reduced viability. The Company has reached settlement agreements covering over 95% of claimants.
Added in current filing · verify on EDGAR →
Between December 2023 and mid-March 2026, the Company resolved a significant number of claims and lawsuits through settlements which were largely covered by insurance.
Prior to mid-March 2026, the Company had been settling claims largely through insurance coverage. The December 2023 recall involved three specific lots of CooperSurgical's LifeGlobal embryo culture media, with claimants alleging embryo loss or reduced viability.
Event · Item 9.01 — Financial Statements and Exhibits
Cooper Companies filed an 8-K attaching a press release dated June 4, 2026; no material event details disclosed in the filing body.
Added in current filing · verify on EDGAR →
Press Release dated June 4, 2026 of The Cooper Companies, Inc.
The 8-K attaches a press release dated June 4, 2026. The filing body does not disclose the content or subject matter of the press release, so the nature and materiality of the event cannot be determined from this 8-K alone. Investors should review Exhibit 99.1 for details.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify